Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
| Cat.No. | Product Name | Price |
|---|---|---|
| CSC-DC004113 | Panoply™ Human DDA1 Knockdown Stable Cell Line | Inquiry |
| CSC-SC004113 | Panoply™ Human DDA1 Over-expressing Stable Cell Line | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| AD04667Z | Human DDA1 adenoviral particles | Inquiry |
| LV10441L | human DDA1 (NM_024050) lentivirus particles | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| SHH275529 | shRNA set against Human DDA1 (NM_024050.5) | Inquiry |
| SHH275533 | shRNA set against Mouse DDA1 (NM_025600.1) | Inquiry |
| SHH275537 | shRNA set against Rat DDA1 (NM_001134790.1) | Inquiry |
| SHW002001 | shRNA set against Chicken DDA1 (NM_001031408) | Inquiry |
| SHW018231 | shRNA set against Danio rerio DDA1 (NM_213127) | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| CDFR010007 | Rat Dda1 cDNA Clone(NM_001134790.1) | Inquiry |
| MiUTR4H-TG02609 | DDA1 miRNA 3'UTR clone | Inquiry |
| CDCB163476 | Chicken DDA1 ORF Clone (NM_001031408) | Inquiry |
| CDCB179706 | Danio rerio DDA1 ORF Clone (NM_213127) | Inquiry |
| CDCR257305 | Mouse Dda1 ORF Clone(NM_025600.1) | Inquiry |
| CDCR377018 | Rat Dda1 ORF Clone(NM_001134790.1) | Inquiry |
| CDCS415644 | Human DDA1 ORF Clone (BC000615) | Inquiry |
The DET1 and DDB1 associated 1 (DDA1) gene is an essential regulator of various cellular processes, including cell cycle progression, DNA repair, and genome stability. mutations in the DDA1 gene have been linked to various human diseases, including cancer and neurodegenerative disorders.
The DDA1 gene encodes a protein of the same name, which is a member of the BTB (Broad Complex, Tramtrack, and Bric-a-brac) protein family. The DDA1 protein is a nuclear protein that contains a BTB domain, a C-terminal region, and a variable N-terminal region. The BTB domain is responsible for the protein's DNA binding activity, while the C-terminal region is involved in protein-protein interactions. The N-terminal region contains several conserved domains, including the WD-repeat domain, which is responsible for the protein's role in cell cycle regulation. DET1 and DDB1 Associated 1 (DDA1) is a gene associated with melanoma, a malignant skin cancer. It is located on chromosome 9 and is involved in the regulation of cell growth and differentiation. The structure of the DDA1 gene consists of 11 exons and 10 introns, encoding a protein of 351 amino acids. The gene is expressed in various tissues, including the skin, and its expression is often decreased in melanoma tumors. Understanding the structure and function of the DDA1 gene is important for developing targeted therapeutics against melanoma.
DDA1 plays a crucial role in cell cycle regulation, particularly in the G1/S transition. The protein interacts with androgen receptor (AR), retinoblastoma protein (Rb), and CDK4/6, which are key players in the cell cycle regulatory machinery. DDA1 binds to the AR and Rb, and inhibits their transcriptional activity, thereby promoting cell cycle progression. In addition, DDA1 interacts with CDK4/6 and promotes their kinase activity, which is essential for the G1/S transition.
DDA1 has also been implicated in DNA repair and genome stability. The protein interacts with various DNA repair enzymes, including DNA polymerase delta (polδ) and DNA ligase IV (LIG4), and promotes their activity. This interaction is crucial for the repair of DNA double-strand breaks (DSBs), which are common sources of genome instability. DDA1 also interacts with the checkpoint kinase CHK1, which is involved in the cellular response to DNA damage. Thus, DDA1 plays a crucial role in maintaining genome stability by regulating DNA repair pathways.
mutations in the DDA1 gene have been identified as a cause of various human diseases. For example, mutations in the DDA1 gene have been linked to cancer, particularly breast cancer. In addition, DDA1 has been implicated in neurodegenerative disorders such as Alzheimer's disease and amyotrophic lateral sclerosis (ALS). DDA1 has also been identified as a potential therapeutic target for various diseases, including cancer and neurodegenerative disorders.
References: